Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)

SHE:300255 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 2, 2025	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	17,968	11,957	5,036	7,472	5,693	5,086
Market Cap Growth	-2.47%	137.41%	-32.59%	31.26%	11.92%	33.01%
Enterprise Value	19,948	14,091	6,817	8,617	6,631	5,394
Last Close Price	19.55	13.01	5.47	8.09	6.15	5.40
PE Ratio	-	-	287.58	31.99	22.52	22.58
Forward PE	-	12.44	12.44	12.44	12.44	12.44
PS Ratio	14.31	8.48	2.16	2.52	2.41	2.46
PB Ratio	9.88	6.64	1.65	2.43	2.00	1.87
P/TBV Ratio	7.96	8.02	1.80	2.68	2.20	2.00
P/FCF Ratio	126.26	-	-	-	-	-
P/OCF Ratio	39.01	354.53	1611.41	2602.11	-	-
EV/Sales Ratio	18.91	9.99	2.92	2.90	2.81	2.60
EV/EBITDA Ratio	-	41.33	22.68	15.64	15.09
EV/EBIT Ratio	-	63.13	26.59	17.98	17.68
EV/FCF Ratio	140.18	-	-	-	-	-
Debt / Equity Ratio	1.32	1.32	0.82	0.57	0.47	0.31
Debt / EBITDA Ratio	-	-	15.10	4.58	3.14	2.38
Debt / FCF Ratio	16.46	-	-	-	-	-
Asset Turnover	0.21	0.27	0.42	0.61	0.56	0.53
Inventory Turnover	0.84	0.85	0.56	0.60	0.45	0.45
Quick Ratio	0.31	0.29	0.72	0.52	0.67	0.80
Current Ratio	1.14	1.19	2.18	1.97	2.12	2.13
Return on Equity (ROE)	-39.82%	-51.43%	0.33%	7.81%	9.01%	8.48%
Return on Assets (ROA)	-11.64%	-13.46%	1.20%	4.15%	5.41%	4.90%
Return on Capital (ROIC)	-12.76%	-14.74%	1.30%	4.50%	5.94%	5.39%
Return on Capital Employed (ROCE)	-	-	2.50%	9.40%	11.70%	11.10%
Earnings Yield	-4.70%	-10.37%	0.35%	3.13%	4.44%	4.43%
FCF Yield	0.79%	-1.72%	-8.50%	-4.08%	-6.73%	-4.35%
Dividend Yield	0.00%	-	0.09%	0.32%	-	0.24%
Payout Ratio	0.00%	-	708.02%	26.50%	27.08%	31.78%
Buyback Yield / Dilution	8.98%	-4.91%	6.27%	0.23%	0.24%	-0.58%
Total Shareholder Return	8.98%	-4.91%	6.37%	0.55%	0.24%	-0.34%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.